# Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients

> **NCT06601036** · NA · RECRUITING · sponsor: **Tanta University** · enrollment: 70 (estimated)

## Conditions studied

- Sevoflurane
- Sedation
- Awake Fiberoptic Intubation
- Difficult Airway

## Interventions

- **DRUG:** Sevoflurane
- **DRUG:** 2% Xylocaine (2 ml )

## Key facts

- **NCT ID:** NCT06601036
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-17
- **Primary completion:** 2025-02-01
- **Final completion:** 2025-02-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06601036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06601036, "Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06601036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*